Reuters logo
BRIEF-Roche says Avastin receives FDA approval for platinum-sensitive ovarian cancer
December 7, 2016 / 4:40 PM / a year ago

BRIEF-Roche says Avastin receives FDA approval for platinum-sensitive ovarian cancer

Dec 7 (Reuters) - Roche Holding Ag

* Says avastin (bevacizumab) plus chemotherapy receives fda approval for platinum-sensitive recurrent ovarian cancer Further company coverage: (Reporting By Zurich newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below